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Abstract
Background: Protein trans-splicing by naturally occurring split DnaE inteins is used for protein ligation of foreign peptide
fragments. In order to widen biotechnological applications of protein trans-splicing, it is highly desirable to have split inteins
with shorter C-terminal fragments, which can be chemically synthesized.
Principal Findings: We report the identification of new functional split sites in DnaE inteins from Synechocystis sp. PCC6803
and from Nostoc punctiforme. One of the newly engineered split intein bearing C-terminal 15 residues showed more robust
protein trans-splicing activity than naturally occurring split DnaE inteins in a foreign context. During the course of our
experiments, we found that protein ligation by protein trans-splicing depended not only on the splicing junction
sequences, but also on the foreign extein sequences. Furthermore, we could classify the protein trans-splicing reactions in
foreign contexts with a simple kinetic model into three groups according to their kinetic parameters in the presence of
various reducing agents.
Conclusion: The shorter C-intein of the newly engineered split intein could be a useful tool for biotechnological applications
including protein modification, incorporation of chemical probes, and segmental isotopic labelling. Based on kinetic analysis
of the protein splicing reactions, we propose a general strategy to improve ligation yields by protein trans-splicing, which
could significantly enhance the applications of protein ligation by protein trans-splicing.
Citation: Aranko AS, Zu ¨ger S, Buchinger E, Iwaı ¨ H( 2 0 0 9 )In Vivo and In Vitro Protein Ligation by Naturally Occurring and Engineered Split DnaE Inteins. PLoS
ONE 4(4): e5185. doi:10.1371/journal.pone.0005185
Editor: Hilal Lashuel, Swiss Federal Institute of Technology Lausanne, Switzerland
Received January 11, 2009; Accepted March 5, 2009; Published April 13, 2009
Copyright:  2009 Aranko et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the grants from NSERC (298493), Sigrid Juselius Foundation, and the Academy of Finland (118385). The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hideo.iwai@helsinki.fi
¤a Current address: Biochemisches Institut der Universita ¨tZ u ¨rich, Zu ¨rich, Switzerland
¤b Current address: Department of Biotechnology, Chemistry and Environmental Engineering, Aalborg University, Aalborg, Denmark
Introduction
Protein splicing is a post-translational modification, in which an
intervening protein splicing domain (intein) catalyzes ligation of
the two flanking N- and C-terminal segments (N-extein and C-
extein) by a peptide bond and concomitantly excises itself from the
precursor protein [1–3]. Protein splicing can also take place in trans
by ligating separate protein fragments containing each half of a
naturally or artificially split intein (N-intein and C-intein) [4–6].
This protein trans-splicing (PTS) could also work in foreign
contexts where the naturally occurring extein segments are
replaced with other foreign protein sequences of interest.
Therefore, protein trans-splicing can be used for ligation of
polypeptide chains with a peptide bond for protein semi-synthesis,
protein cyclization, segmental isotopic labelling, and site-specific
protein modifications [7–12]. Protein trans-splicing has also been
exploited to control protein functions in living organisms as a post-
translational modification [13–15]. Thus, protein trans-splicing
could be widely used in biotechnology and chemical biology [16].
Inteins usually consist of two domains, namely, a Hint domain
and an endonuclease domain [3]. Since only the Hint domain is
required for protein splicing, several inteins have been minimized
by removing the endonuclease domain for biotechnological
applications [17–19]. The Hint domain could be reduced to as
small as 135 residues, which is presumably the minimal functional
length [19]. Naturally occurring split inteins contain 102–111
residues for N-intein (IntN) and 35–36 residues for C-intein (IntC)
[20]. Short functional fragments of inteins have been of special
interest because they could be easily prepared by chemical
synthesis [12] and widen applications of protein trans-splicing for
chemical modifications and protein semi-synthesis [21]. The
shortest fragment identified so far is the N-terminal 11 residues
of Synechocystis sp. PCC6803 (Ssp) DnaB intein [22]. Our interest
was to identify functional split DnaE inteins with a shorter C-
intein. Shorter C-inteins could be used as a ligation tag that can be
easily synthesized or fused with other proteins for protein ligation.
In this study, a series of split DnaE inteins with new split sites have
been constructed and tested for protein ligation both invivo and invitro
to identify a functional split DnaE intein with a minimal C-terminal
fragment. The robustness of the short C-intein has been tested by
ligation of two domains that could not be ligated by wild-type DnaE
intein. We also investigated the effect of extein sequences on protein
ligation by protein trans-splicing. The effect of various reducing agents
on in vitro protein ligation was tested with several target proteins.
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Construction of split SspDnaE inteins with new split sites
SspDnaE intein is one of the naturally occurring split inteins
widely used in biotechnological applications. Naturally occurring
split inteins can spontaneously induce protein splicing in trans after
association of the N- and C-terminal parts (Figure 1a). In contrast,
artificially split inteins often require tedious denaturation and
renaturation steps to restore protein splicing activity because of
lower solubility of the precursor fragments [23]. Protein ligation of
two flanking foreign sequences through protein trans-splicing by
naturally split inteins usually requires no additional cofactor, but a
few residues of the original extein sequences might be necessary for
efficient splicing [11]. To identify new functional split inteins with
a shorter C-intein, we have moved the split site in naturally split
SspDnaE intein towards the C-terminus by shortening the C-
terminal half (SspDnaE-IntC) systematically by 6–7 residues and
elongating the N-terminal half (SspDnaE-IntN) by approximately
the same lengths (Figure 1b, Figure S1). SspDnaE-IntNs were fused
with the N-terminally His-tagged B1 domain of protein G (GB1),
Figure 1. Protein trans-splicing and locations of the new split sites. (a) Schematic representation of the protein trans-splicing process and
two possible side reactions of N- and C-cleavage. Two fragments of the protein of interest (POI) can be ligated by protein trans-splicing reaction. (b)
Sequence alignment of SspDnaE and NpuDnaE inteins. The locations of the experimentally tested split sites of SspDnaE and NpuDnaE inteins are
indicated by inverse triangles on the top of the primary sequences. The asterisks above inverse triangles indicate the naturally occurring split site.
Filled triangles indicate the split sites, where the split inteins retained protein trans-splicing activity. Open triangles indicate the split sites, where no
protein trans-splicing activity could be detected. The location of the b-strands observed in the crystal structures of SspDnaE intein (PDB code 1ZDE)
[35] and SspDnaB mini-intein (1MI8) [36] are indicated at the bottom of the sequences. The numbering for b-strands is adapted from SspDnaB mini-
intein [36].
doi:10.1371/journal.pone.0005185.g001
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promoter [8]. Previously, we found that the change of the N-
terminal junction sequence of EY from SspDnaE to other
sequences such as GS had little influence on the ligation yield
[24]. Therefore, we used a linker of GS originated from the
restriction site of BamHI between GB1 and SspDnaE-IntNs.
SspDnaE-IntCs were also fused to a chitin binding domain
(CBD), of which expression was controlled by an arabinose
promoter (Figure S1). We kept the sequence of CFNK from the
wild-type junction sequence of SspDnaE and added GT for the
cloning site of KpnI as a linker between SspDnaE-IntCs and CBD
[8]. GB1 and CBD were used here as model proteins because they
are small soluble proteins. The N- and C-precursor proteins were
genetically encoded into two separate plasmids that bear the
compatible RSF3010 and ColE1 origins [8]. Seven plasmids for
each half were constructed for testing in vivo and in vitro protein
ligation (Table S1 and Figure S1).
In vivo protein trans-splicing by the new split SspDnaE
inteins
Protein ligation by the new split inteins was tested in vivo using
the dual vector system previously developed in our group [8]. This
system allows us to conveniently check protein ligation because
protein ligation could be initiated by the induction of the two
precursor fragments with the two inducers, isopropyl-b-D-
thiogalactoside (IPTG) and arabinose, and subsequently analyzed
by SDS-PAGE [24]. Moreover, endogenous auxiliary factors such
as chaperones might improve protein ligation in cells by
promoting correct protein folding. The C-terminal part was
always first induced for 0.5 hours ensuring an excess of the C-
terminal precursor prior to the expression of the N-terminal
precursor, and followed by the induction of the N-terminal
precursor for another 3.5–5.5 hours. The pre-existing C-terminal
precursor protein could be converted into the ligated product
through protein trans-splicing after the association with the N-
terminal part and protein splicing. The expression level of the N-
terminal fragment was monitored by SDS-PAGE in order to avoid
an enormous excess of the N-terminal part, which could
underestimate the ligation yields. Immobilized Metal Affinity
Chromatography (IMAC) was used to purify the N-terminal His-
tagged precursor, the ligated product, and, if any, the cleaved N-
terminal GB1 produced by the side reactions (Figure 1a). If in vivo
protein ligation works with 100% efficiency and if there is no
excess of the N-terminal precursor, only H6-GB1-CBD will be
purified by IMAC through the N-terminal His-tag. If the N- and
C-terminal fragments associate with each other but no protein
splicing is induced, both N- and C-terminal fragments (H6-GB1-
SspDnaE-IntN and SspDnaE-IntC-CBD) will be purified owing to
the affinity between them. Furthermore, if the N- and C-inteins do
not interact or if the C-terminal cleavage reaction is the dominant
reaction after association of the N- and C-inteins, a single band of
the N-terminal precursor is expected to be visible in the SDS gel.
In some cases, during protein purification and sample preparation
for SDS-PAGE, reactions such as splicing and cleavages could take
place, which produced smaller bands of cleaved and spliced
products. The ligated product was confirmed by mass-spectrom-
etry (Figure S2). We could identify the ligated product H6-GB1-
CBD in the elution fractions from IMAC only for the
combinations of SspDnaE-IntN123/SspDnaE-IntC36 (wild-type),
SspDnaE-IntN130/SspDnaE-IntC30, SspDnaE-IntN137/SspDnaE-
IntC23, and SspDnaE-IntN144/SspDnaE-IntC16 (Figure 2a). The
ligation yields were estimated from the ratios between the
intensities of the ligated product and one of the most abundant
residual precursor fragments in the SDS gel, which were ca. 3%
for SspDnaE-IntN144/SspDnaE-IntC16, ca. 1% for SspDnaE-
IntN137/SspDnaE-IntC23, and ca. 16% for SspDnaE-IntN130/
SspDnaE-IntC30. These efficiencies might be underestimated if
an excess of the N-terminal part was present during the expression
due to the co-purification of the N-terminal precursor containing
an N-terminal His-tag. The highest yield was estimated for the
wild-type combination of SspDnaE-IntN123/SspDnaE-IntC36
(67%). Albeit the amounts of the ligated products produced by
the newly engineered inteins were very small, the protein ligation
was still detectable by SDS-PAGE. The split site of SspDnaE-
IntN144/SspDnaE-IntC16 was the split site of the shortest C-intein
retaining detectable splicing activity. However, the ligation
efficiency was significantly lower than that of wild-type SspDnaE
intein because of the low splicing activity and the side reactions.
The pairs of SspDnaE-IntN151/SspDnaE-IntC9 and SspDnaE-
IntN154/SspDnaE-IntC6 could not induce protein trans-splicing as
only the N-terminal precursor was purified, indicating there was
no significant interaction between them. On the other hand, the
shortest C-intein construct of SspDnaE-IntC3 was purified together
with the N-terminal SspDnaE-IntN157 indicating that there was
sufficient interaction between them. However, we could not
identify any ligated product although there was a band at
18.4 kDa in the SDS gel indicating a small amount of the N-
cleavage reaction that produced IntN.
Split NpuDnaE intein with the new split site
The low ligation efficiencies of the newly functional split sites of
SspDnaE intein suggest little practical use of these new split inteins.
However, we have recently discovered that DnaE intein from Nostoc
punctiforme (Npu) has more robust protein trans-splicing activity than
that of SspDnaE intein and is also more tolerant of amino acid
replacements at the C-terminal splicing junction [24]. Our previous
study indicated that the N-terminal part (NpuDnaE-IntN)i s
responsible for the higher ligation efficiency [24]. Therefore, we
wereinterestedinintroducingthenewsplitsiteofSspDnaE intein into
NpuDnaE intein to obtain sufficient protein trans-splicing activity for
practical use. The new split site with the C-terminal 16 residues in
SspDnaE is located between b-strands 10 and 11 (Figure 1b). We
decided to shorten the C-intein by one more residue in NpuDnaE
intein because based on the NMR structures of NpuDnaE intein (PDB
entry, 2KEQ) the split site wouldbestill in the loop betweenb-strands
10 and 11 [25,26]. Protein ligation in vivo by NpuDnaE-IntN123/
NpuDnaE-IntC15 is demonstrated in Figure 2b. The C-terminal part
(NpuDnaE-IntC15-GB1) was induced first by L-arabinose (lane 2,
Figure 2b). After the consecutive induction of the N-terminal part
(H6-GB1-NpuDnaE-IntN123), a large amount of the ligated product
(H6-GB1-GB1) was accumulated (lane 3 and 4, Figure 2b). The
fraction purified by IMAC contained almost no precursor proteins
and the ligation was confirmed by mass spectrometry (lane 5,
Figure 2b and Figure S3). We estimated the ligation efficiency to be
ca. 96%, which is significantly better than any of the tested
combinations of the newly split SspDnaE inteins. We also tested
protein ligation by the combination of NpuDnaE-IntN123/SspDnaE-
IntC16, which resulted in similar ligation efficiency (data not shown).
This result emphasizes the dominant contribution of the N-intein to
the ligation efficiency and suggests that the sequence variation
between NpuDnaE-IntC15 and SspDnaE-IntC16 (the sequence identity
is 66%) has little influence on protein trans-splicing efficiency.
Protein ligation of SH3 domains by the naturally split
NpuDnaE intein
The robustness of naturally split NpuDnaE intein encouraged
us to use NpuDnaE intein as a general tool for protein ligation
and to apply it to biologically relevant proteins [24]. The Src
Protein Ligation by PTS
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in multi-domain proteins. Therefore, we were interested in
protein ligation of the two SH3 domains from c-Crk-II adaptor
protein [27]. Despite the robustness of NpuDnaE intein, protein
ligation of the two SH3 domains by wild-type NpuDnaE intein
was not possible, because the side reactions were dominating the
trans-splicing and producing mainly cleaved products (Figure 3a
and 3c). When the N-terminal SH3 (nSH3) was replaced with
the model protein GB1, both in vivo and in vitro ligation of the
two proteins by protein trans-splicing was still not possible with
high yields (Figure 3b and 3d, Figure S4). On the other hand,
the ligation of the two proteins in vitro as well as in vivo was
significantly improved after replacing the C-terminal SH3 (cSH3)
with GB1 (Figure 4a, Table 1). These observations indicate that
protein trans-splicing can be significantly influenced not only by
the sequences near the splicing junctions but also by the exteins,
which brings additional complexity to protein trans-splicing.
Furthermore, the replacement of the C-terminal precursor
protein suggests that the C-terminal fragment containing cSH3
negatively affects the protein ligation.
The effect of reducing agent on trans-splicing
In theory, protein trans-splicing does not require any thiol agents
for the reaction [3]. However, both N- and C-inteins of NpuDnaE
Figure 2. In vivo protein ligations by the newly engineered split SspDnaE and NpuDnaE inteins. (a) SDS-PAGE analysis of in vivo protein
ligations by the newly engineered split SspDnaE inteins after purification with Ni-NTA. The combinations of SspDnaE-IntN and SspDnaE-IntC are
indicated on the top of the lanes. (b) In vivo protein ligation by NpuDnaE intein with the newly engineered split site (NpuDnaE-IntN123/C15). Lane 1,
before induction; lane 2, 1.5 hours after induction only with arabinose; lane 3, 1.5 hours after additional induction with IPTG; lane 4, 3 hours after
induction with IPTG and arabinose; lane 5, elution from Ni-NTA column.
doi:10.1371/journal.pone.0005185.g002
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intermolecular disulfide bonds and they may prevent the
appropriate association of the two fragments. Therefore, it is
desirable to keep the reaction under reducing conditions with a
sulfhydryl reductant. In a previous study on SspDnaE intein, it has
been reported that the presence of 50 mM dithiothreitol (DTT)
would almost totally block protein trans-splicing and instead shunt
the reaction to trans-cleavage [28]. As a sulfhydryl reductant, we
have tested two thiol agents (DTT and 2-mercaptoethane sulfonic
acid, MESNA) and a trialkylphosphine (tris(2-carboxyethyl)pho-
sphine, TCEP) that is unreactive with thiol groups such as cysteine
(Figure 4c). In contrast to the previous report, we found that the
effect of various reducing agents on protein ligation was negligible
for the ligation between nSH3 and GB1 (Figure 4c) as well as for
the ligation of the two SH3 domains (data not shown). In the case
of nSH3 and cSH3, the reaction was always dominated by trans-
cleavage rather than trans-splicing (Table 1, Figure 3). It was not
possible to improve the ligation of those SH3 domains by replacing
the reducing agent. For the ligation of nSH3 and GB1, trans-
splicing was always observed regardless of the reducing agents
used (Table 1, Figure 4c). To understand these puzzling effects, we
analyzed the kinetics of the protein ligation. It is well accepted that
protein-splicing reaction involves the four concerted steps: (1) N-S
acyl shift, (2) trans-thioesterification, (3) Asn cyclization, and (4) S-
N acyl shift, and possibly undesired side reactions of N- and C-
cleavage (Figure 1a) [29]. The detailed kinetics of the individual
steps has been previously characterized for SspDnaE intein [28].
We decided to approximate the reactions with a simple kinetic
model as depicted in (I), in which the entire reaction was divided
into the two parallel reactions: trans-splicing and cleavage reactions
because the two reactions are both irreversible processes. In this
model, we also assume that the formation of the precursor
Figure 3. Protein ligation in vivo and in vitro by the naturally occurring split NpuDnaE intein. (a) Protein ligation of nSH3 and cSH3 in vivo
by naturally occurring split NpuDnaE intein. Lane 0, before induction; lane 1, 1 hour after the induction with IPTG and arabinose; lane 2, 2 hours; lane
3, 4 hours; lane 4, 6 hours. (b) Protein ligation of GB1 and cSH3 in vivo by the wild-type NpuDnaE intein. Lane 0, before induction; lane 1, 2 hours after
the induction with IPTG and arabinose; lane 2, 4 hours; lane 3, 6 hours. In vitro protein ligation (c) of nSH3 and cSH3 (d) of GB1 and cSH3 in the
presence of 50 mM DTT. Lane 0, 0 min after the mixing; lane 1, 10 min; lane 2, 3 hours; lane 3, 24 hours for (c). Lane 0, 0 min after the mixing; lane 1,
3 min; lane 2, 3 hours; lane 3, 24 hours for (d). Asterisks indicating the bands below 14.4 kDa in (c) and (d) are impurities from the purification of H6-
NpuIntC36-cSH3.
doi:10.1371/journal.pone.0005185.g003
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dissociation constant is much smaller than the protein concentra-
tion used in the experiments [28].
C BD
kunprod
A DA
ktrans B ðIÞ
A=precursor complex, B=ligated product, C=cleaved prod-
uct, ktrans=1
st order kinetic constant for trans-splicing, and
kunprod=apparent 1
st order kinetic constant for all unproductive
side reactions including the N- and C-terminal cleavage reactions.
Time courses of the products can be formulated by the following
rate equations.
Figure 4. In vitro protein ligation of nSH3 and GB1 by the naturally occurring split NpuDnaE intein. (a) Time course of the protein ligation
of nSH3 and GB1 by naturally occurring split NpuDnaE intein in the presence of 50 mM DTT. Lane 1, 0 min after the mixing; lane 2, 3 min; lane 3,
10 min; lane 4, 30 min; lane 5, 1 hour; lane 6, 3 hours; lane 7, 22 hours. (b) Kinetic analysis of the protein ligation from the SDS-PAGE. (c) SDS-PAGE
analysis of the ligation reaction after overnight incubation in the presence of different reducing agents.
doi:10.1371/journal.pone.0005185.g004
Table 1. The final yields of the protein ligation by protein trans-splicing.
Intein N-extein C-extein Yield (%) with 50 mM DTT Yield (%) with 0.5 mM TCEP
NpuDnaE-IntN102/C36 (wild-type) nSH3 cSH3 n.d. n.d.
GB1 cSH3 n.d. n.d.
nSH3 GB1 77610 6168
NpuDnaE-IntN123/C15 nSH3 cSH3 27610 5067
Smt3 GB1 9636 5 67
n.d., not detectable.
doi:10.1371/journal.pone.0005185.t001
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dt
~{ kunprodzktrans

A ½  ,
dB ½ 
dt
~ktrans A ½  ,
dC ½ 
dt
~kunprod A ½ 
ðIIÞ
These equations can be easily solved [30]. The yield of the
ligation at an infinite time can be derived from the two kinetic
constants for trans-splicing and cleavage according to Eq. (III).
E % ðÞ ~100|
ktrans
ktranszkunprod
ðIIIÞ
With this model, we should be able to estimate ligation yields
from the rate constants of trans-splicing and side reactions, and vice
versa. For the ligation between nSH3 and GB1, 2.360.2610
24
(s
21) was estimated for ktrans in the presence of 50 mM DTT
(Figure 4b). According to Eq. (III) using the obtained kinetic
constants and the reported DTT induced cleavage rate constant
for SspDnaE intein (1.060.5610
23 (s
21)) [28], the ligation yield
for nSH3 and GB1 is expected to be 12–33%. However, the
obtained final yield of close to 80% might suggest that the rate
constant of DTT induced cleavage is about 1610
24 with this
system (Table 1). Trans-splicing was not detectable for nSH3 and
cSH3, but the side reactions were dominant with the kinetic
constant kunprod=5.460.4610
24 (s
21) in the presence of 50 mM
DTT (data not shown). Although the replacement of DTT with
TCEP as a reducing agent slowed the unproductive cleavage
reactions, trans-splicing was not detectable. This suggests that trans-
splicing reaction occurs at a significantly slower rate than the
cleavage reaction. This model assumes that the association rates
are fast and that the dissociation rates are similarly low for
different exteins compared with the experimental concentration.
Therefore, when the estimation of the yield is largely discrepant
with the kinetic constants, the limiting factor is likely to be imposed
by the association rate. Thus, this simple model and the kinetic
analysis might provide a useful tool to predict final yields as well as
to identify the rate-limiting step in protein trans-splicing reaction.
Protein ligation by the newly engineered split NpuDnaE
From the aforementioned results with the SH3 domains, we
assumed that the C-intein fused with cSH3 is the limiting factor for
the protein ligation of two SH3 domains, inducing fast cleavage
reactions. Webelieve that cSH3 probably interfereswithassociation
of N- and C-inteins of wild-type NpuDnaE intein and that the
shorter C-intein might not interfere the ligation of the two SH3
domains. Therefore, we decided to replace the intein with the newly
engineered NpuDnaE intein (NpuDnaE-IntN123/NpuDnaE-IntC15)
Figure 5. Protein ligation of two SH3 domains by the newly engineered split NpuDnaE intein. (a) SDS-PAGE analysis of the time course
from the protein ligation reaction of nSH3 and cSH3 in the presence of 0.5 mM TCEP. Lane 1, 0 min after the mixing; lane 2, 3 min; lane 3, 10 min;
lane 4, 30 min; lane 5, 1 hour; lane 6, 3 hours; lane 7, 22 hours. (b) Kinetic analysis of the protein ligation from the SDS-PAGE.
doi:10.1371/journal.pone.0005185.g005
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intein could indeed ligate nSH3 and cSH3 that were not possible to
be ligated by the naturally occurring split NpuDnaE intein. It
demonstrates the effectiveness of the shorter C-intein in the case of
difficult ligations such as the one between the two SH3 domains.
The kinetic constants for trans-splicing were estimated to be
4.860.3610
25 (s
21) in the presence of 0.5 mM TCEP (Figure 5b).
Thus,theengineeredsplitNpuDnaEinteincansignificantlyimprove
the protein ligation by accelerating the trans-splicing reaction.
Protein ligation of Smt3 and GB1
Because of the strong influence of the exteinsequences on protein
trans-splicing, we wanted to test another small protein with a similar
size, the yeast ubiquitin-like protein Smt3, for protein ligation [31].
Protein ligation of His-tagged Smt3 and GB1 by NpuDnaE-IntN123
wastestedinthepresence ofeither50 mMDTTor0.5 mMTCEP.
The protein ligation of Smt3 and GB1 responded differently to the
two different reducing agents. When 0.5 mM TCEP was used, the
yield was more than 60–70%. On the contrary, only about 10% of
the protein ligation was achieved in the presence of 50 mM DTT,
where the cleavage reaction dominated. In this case the kinetic
constant for trans-splicing in presence of 0.5 mM TCEP was
estimated to be 8.360.7610
25 (s
21). DTT induced the dominant
cleavage reaction with a kinetic constant of 9.261.2610
24 (s
21)
(Figure 6). The protein ligation yield in the presence of 50 mM
DTT is expected to be around 10% as it can be derived from Eq.
(III) with an assumption that trans-splicing rates are similar for both
DTT and TCEP. This is in good agreement with the yield obtained
experimentally, suggesting that the simple model is appropriate for
roughly estimating the yield without any intricate methods.
Discussion
In this article, we demonstrated that C-intein from SspDnaE
and NpuDnaE inteins could be shortened to C-terminal 16 or 15
residues without abolishing protein trans-splicing activity. The
newly engineered split NpuDnaE intein bearing the C-terminal 15
residues as C-intein retained robust protein trans-splicing activity.
The use of the shorter C-intein was even more effective for the
ligation of the two SH3 domains that could not be ligated by the
wild-type split DnaE inteins. The shorter length of C-intein of the
engineered split NpuDnaE intein could be attractive for chemical
synthesis and suitable for incorporation of chemically modified
peptides by protein trans-splicing [32]. Moreover, the kinetic
analysis of the ligation reaction could be important because the
kinetic parameters are the key factor determining the ligation
yields. The analysis using a simple parallel model to approximate
the reaction could be a convenient tool to investigate the rate-
limiting steps in the reaction and to estimate the ligation yields
based on the kinetic parameters. Protein trans-splicing reaction in
foreign contexts can be categorized into three groups. In the first
group only side reactions of cleavages can be observed. Various
reducing agents such as TCEP or DTT have little effect on
improving protein ligation in this group. In this case, the cleavage
reaction has a typical kinetic constant of .1610
24 (s
21) and the
trans-splicing rate is much slower than the cleavage rate. In the
Figure 6. Protein ligation of Smt3 and GB1 by the newly engineered split NpuDnaE intein. Time courses and kinetic analysis of protein
ligation in the presence of (a) 0.5 mM TCEP or (b) 50 mM DTT. SDS-PAGE: lane 1, 0 min after the mixing; lane 2, 3 min; lane 3, 10 min; lane 4, 30 min;
lane 5, 1 hour; lane 6, 3 hours; lane 7, 24 hours.
doi:10.1371/journal.pone.0005185.g006
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ligation by protein trans-splicing can be observed. Here, the trans-
splicing reaction is faster (.1610
24 (s
21)) than the unproductive
cleavage reactions induced by various reducing agents. In the third
group, trans-splicing reaction is slower than the side reactions
induced by DTT, but faster than the side reactions in the presence
of TCEP. Therefore, the reducing agent could greatly influence
the final yield. This is presumably because the thiol group of DTT
is a nucleophile competing with the thiol of the first cysteine of C-
intein and induces dominant cleavage reactions. However, the side
reactions in the presence of TCEP are usually slower because it
has no thiol group that functions as nucleophile competing with
trans-splicing reaction.
In summary, we could create new functional split inteins with
shorter C-inteins,whichretained trans-splicingactivity.Proteintrans-
splicing was found to be dependent on the protein sequences of the
exteins even if the sequence around the splicing junctions were
identical. How the exteins influence protein trans-splicing remains
unclear. However, monitoring the kinetics of the protein trans-
splicing reaction could be a useful tool to identify the rate-limiting
steps in protein ligation reaction. To achieve a higher yield of
protein ligation by protein trans-splicing, it is of importance to keep
the competing side reactions slower than the trans-splicing reaction
by replacing the reducing agent with non-thiol reducing agents such
as TCEP or by accelerating the trans-splicing reaction using a more
efficientsplit intein. The ligation between self-contained domains by
protein trans-splicing was investigated in this article. However, the
model describing the relation between trans-splicing and side
reactions should be generally applicable even for the ligation within
a single domain although such ligation may require refolding of the
precursors which could be a more dominant factor affecting the
yield. Further understanding of the factors influencing protein trans-
splicing reaction rates such as folding processes of split inteins and
engineering of split inteins could make protein trans-splicing a more
versatile tool for protein modification, protein semi-synthesis, and
segmental isotopic labelling.
Materials and Methods
Construction of plasmids
The N-terminal fragments of SspDnaE intein (SspDnaE-IntN)o f
various lengths were previously constructed [24]. The coding
sequences of SspDnaE-IntNs were subcloned into pJJDuet30
between BamHI and HindIII sites [8], resulting in the sequences
coding for H6-GB1-SspDnaE-IntNs (Figure. S1). SspDnaE-IntCso f
various lengths were constructed from the plasmid pSZRS1
containing the gene of the full-length SspDnaE-IntC and the chitin
binding domain (CBD) using synthetic oligonucleotides (Table S1)
and cloned into pBAD vector (Figure S1).
The plasmid for H6-GB1-NpuDnaE-IntN123 was constructed by
replacing the codon of residue 124 of the full-length NpuDnaE
intein with a stop codon in the plasmid of pSKDuet16, resulting in
pHYDuet36 [26]. The plasmid pSKDuet16 contains an additional
two mutations of HM to LG at the front of GB1 due to the
replacement of NdeI site by AvrII site, compared with the plasmids
derived from pJJDuet30 [8]. The gene of NpuDnaE-IntC15-GB1
was amplified from pSKDuet16 and cloned into a pBAD vector
(pHYBAD44) [24]. NpuDnaE-IntN123 was subcloned from pHY-
Duet36 into pHYRSF53LA using BamHI and HindIII sites, which
resulted in pHYRSF53-36 coding for H6-Smt3-NpuDnaE-IntN123
[26].
The gene of the N-terminal SH3 domain was amplified from
pAT044 [33] with the two oligonucleotides (#HK009 and
#SK202) and cloned into pHYRSF1-12 using NdeI and AhdI
sites, which resulted in pTMRSF07 (Table S1). The plasmid
pHYRSF1-12 was previously constructed by transferring the gene
of GB1 and the N-terminal NpuDnaE from pSKDuet1 into pRSF-
1b using NcoI and HindIII sites. The plasmid of pHYRSF1-12
contains additional mutations of GS to TK to introduce AhdI site
at the front of NpuDnaE intein. The gene of the C-terminal SH3
domain was amplified from pAT044 with the two oligonucleotides
(#SK199 and #SK200) and cloned into pSKBAD2 using KpnI
and HindIII sites (pHYBAD2-03) (Table S1). The plasmid
pSARSF03, which codes for H6-NpuDnaE-IntC36-cSH3, was
constructed by subcloning the genes of IntC36 and cSH3 into
pHYRSF1-2 by NdeI and HindIII sites. The plasmids
(pMMRSF17 for nSH3 and pMMRSF1-16 for cSH3) coding for
the SH3 domains fused to the newly designed split NpuDnaE intein
were previously described [34].
Expression and purification of new split inteins
His-tagged DnaE-IntNs fused with GB1, Smt3, or SH3 domains
were purified using His-Trap columns (GE Healthcare) under
native condition. The DnaE-IntCs without a His-tag fused with
GB1 were purified with IgG sepharose (GE Healthcare) according
to the manufacturer’s protocol. The eluted fractions of DnaE-IntCs
were dialyzed against 10 mM Tris, 500 mM NaCl, 1 mM EDTA,
pH 7.0 prior to protein ligation.
In vivo protein ligation
Each pair of the two plasmids encoding N- or C-terminal
precursor proteins was transformed into E.coli ER2566 (New
England Biolabs) for protein expression. The cells bearing these
two plasmids were grown in 25 ml LB medium supplemented with
100 mg/ml ampicillin and 25 mg/ml kanamycin. The plasmid
containing DnaE-IntC was first induced for 0.5 hours at a final
concentration of 0.04% arabinose when the cell density reached
OD600=0.5–0.8, followed by an additional induction of the N-
terminal part with addition of a final concentration of 1 mM
isopropyl-b-D-thiogalactoside (IPTG). Expression was carried out
for another 4–5.5 hours. The cells were spun down at 4,5006g for
10 min and stored at 220uC for further purification. The
harvested cells were lysed by ultrasonication in lysis buffer
(50 mM sodium phosphate, 300 mM NaCl, 10 mM imidazole,
pH 8.0). The cell debris was removed from the protein solution by
centrifugation for 15 min at 18,0006g. The entire amount of the
supernatant was loaded on a Ni-NTA spin column (Qiagen)
equilibrated with lysis buffer and centrifuged for 2 min at 7006g.
The column was washed twice with 600 ml washing buffer (50 mM
sodium phosphate, 300 mM NaCl, 30 mM imidazole, pH 8.0).
The bound protein was eluted from the spin column by washing
twice with 200 ml elution buffer (50 mM sodium phosphate,
300 mM NaCl, 250 mM imidazole, pH 8.0).
In vitro protein ligation
Equal amounts of the two precursor fragments (final concen-
trations of 15 mM) were mixed in the presence of final
concentrations of 1 mM EDTA and either 50 mM DTT
(dithiothreitol), 20 mM MESNA (2-mercaptoethane sulfonic acid),
or 0.5 mM TCEP (tris(2-carboxyethyl)phosphine). The reactions
were incubated at 25uC with shaking. The samples for SDS-PAGE
analysis were typically taken at 0 min, 3 min, 10 min, 30 min,
1 hour, 3 hours, and 24 hours after mixing. The reactions were
stopped by adding an equal amount of 16 SDS sample buffer
containing 2-mercaptoethanol and stored at 220uC for over night.
The samples were loaded on 18% SDS polyacrylamide gels after
the incubation at 95uC for 5 min. The ligation yields were
estimated from the intensities of the bands in the SDS-gels colored
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by quantifying the scanned gels with ImageJ (NIH). The amounts
of proteins were calculated with the assumption that the staining
dye binds to the proteins equally. The errors were estimated by at
least three independent reactions.
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